Guardant Health Azar II converts award to 137 shares

The award's vesting schedule provides that 25% vested on September 12, 2026, with the remaining 75% vesting monthly for the following three years.

Rhea-AI Filing Summary

Guardant Health, Inc. director Alex M. Azar II reported converting 137 restricted stock units into 137 shares of common stock on October 12, 2026. After the transaction, he directly held 4,816 restricted stock units and 962 shares of common stock.

The award was granted September 12, 2025 and vests over four years: 25% vested September 12, 2026, and the remaining 75% vests monthly for the three-year period thereafter.

Insider Trade Summary

137 shares exercised/converted

Exercise 2 txns

Insider Azar Alex M II

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F1, F2	137	$0.00	$0.00
Exercise	Common Stock	137	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 4,816 contracts (Direct); Common Stock — 962 shares (Direct)

Footnotes (2)

1. F1. The restricted stock unit award was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award vested on September 12, 2026 and the remaining 75% vests monthly for the three-year period thereafter.
2. F2. Not applicable for Restricted Stock Units.

Key Figures

Restricted stock units converted: 137 restricted stock units Common shares acquired in conversion: 137 shares of common stock Restricted stock units held after transaction: 4,816 restricted stock units +3 more

6 metrics

Restricted stock units converted 137 restricted stock units October 12, 2026

Common shares acquired in conversion 137 shares of common stock October 12, 2026

Restricted stock units held after transaction 4,816 restricted stock units Direct holdings following the October 12, 2026 transaction

Common shares held after transaction 962 shares of common stock Direct holdings following the October 12, 2026 transaction

Award portion vested 25% Vested September 12, 2026

Award portion vesting monthly 75% Vests monthly for the three-year period after September 12, 2026

Key Terms

restricted stock unit award, vests monthly

2 terms

restricted stock unit award financial

"The restricted stock unit award was granted on September 12, 2025"

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

vests monthly financial

"the remaining 75% vests monthly for the three-year period thereafter"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GH shares did Alex M. Azar II receive from the RSU conversion?

Alex M. Azar II converted 137 restricted stock units into 137 shares of common stock on October 12, 2026. Afterward, he directly held 962 shares of common stock and 4,816 restricted stock units.

What was the vesting schedule for Alex M. Azar II's Guardant Health RSU award?

The award was granted on September 12, 2025 and vests over a four-year period. 25% vested on September 12, 2026, and the remaining 75% vests monthly for the three-year period thereafter.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 05:11 PM EDT Accepted by SEC EDGAR 10/13/2026 - 05:10 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Azar Alex M II

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/12/2026		M		137	A	$0	962	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	10/12/2026		M			137	(1)	(2)	Common Stock	137	$0	4,816	D

Explanation of Responses:

1. The restricted stock unit award was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award vested on September 12, 2026 and the remaining 75% vests monthly for the three-year period thereafter.

2. Not applicable for Restricted Stock Units.

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Alex M. Azar II	10/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)